La lecture à portée de main
Editeur
Suivre CELLADON-CORPORATION
Documents
Celladon Corporation Announces First European Patient Dosed in CUPID Phase 2b Trial of MYDICAR® for Advanced Heart Failure
Documents
Médias
Celladon Corporation Announces First European Patient Dosed in CUPID Phase 2b Trial of MYDICAR® for Advanced Heart Failure
2 pages
English